CSIMarket



Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 
 

SGBI's EPS from Cont. Operations Growth by Quarter and Year

Sangui Biotech International Inc's EPS from Cont. Operations results by quarter and year




SGBI EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter June - - - -
III Quarter March 0.00 - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -



SGBI EPS from Cont. Operations third quarter 2022 Y/Y Growth Comment
Sangui Biotech International Inc in the third quarter 2022 recorded EPS loss from Cont. Operations of $ 0.00 .

According to the results reported in the third quarter 2022, Sangui Biotech International Inc achieved the best EPS from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While Sangui Biotech International Inc' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




SGBI EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Sangui Biotech International Inc's third quarter 2022 EPS from Cont. Operations $ 0.00 SGBI's Income Statement
Sangui Biotech International Inc's third quarter 2021 EPS from Cont. Operations $ 0.00 Quarterly SGBI's Income Statement
New: More SGBI's historic EPS from Cont. Operations Growth >>


SGBI EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Sangui Biotech International Inc's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q EPS from Cont. Operations Comment


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q EPS from Cont. Operations Comment


Sangui Biotech International Inc's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
In the Mar 31 2022 period, Sangui Biotech International Inc's cumulative trailing twelve month EPS from Cont. Operations remained unchanged compare to the same period a year ago.

Sangui Biotech International Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
In the Mar 31 2022 period, Sangui Biotech International Inc's cumulative trailing twelve month EPS from Cont. Operations remained unchanged compare to the same period a year ago.

Sangui Biotech International Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
SGBI's EPS from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for SGBI's Competitors
EPS from Cont. Operations Growth for Sangui Biotech International Inc's Suppliers
EPS from Cont. Operations Growth for SGBI's Customers

You may also want to know
SGBI's Annual Growth Rates SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Dividend Payout Ratio
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2022
Msa Safety Inc-3.23%$ -3.226 
Lemaitre Vascular Inc-3.45%$ -3.448 
Idexx Laboratories Inc-3.77%$ -3.766 
Merit Medical Systems Inc-5.00%$ -5.000 
Addus Homecare Corporation-5.26%$ -5.263 
National Research Corporation-5.56%$ -5.556 
Amgen Inc.-5.61%$ -5.614 
Petmed Express Inc.-11.44%$ -11.436 
Organon and Co.-12.18%$ -12.179 
Regeneron Pharmaceuticals Inc.-13.80%$ -13.800 
Natus Medical Inc-14.29%$ -14.286 
Intuitive Surgical Inc.-15.24%$ -15.235 
Quest Diagnostics Inc-15.63%$ -15.625 
Universal Health Services Inc.-16.67%$ -16.667 
Encompass Health Corporation-18.52%$ -18.519 
Biomx Inc.-22.86%$ -22.857 
Davita Inc.-22.94%$ -22.936 
Biogen Inc.-23.70%$ -23.704 
Hologic Inc-24.58%$ -24.583 
Lifevantage Corp-25.00%$ -25.000 
Integrated Biopharma Inc-25.00%$ -25.000 
Molecular Templates Inc.-25.49%$ -25.490 
Fulgent Genetics Inc.-26.87%$ -26.868 
Integra Lifesciences Holdings Corp-27.78%$ -27.778 
Reynolds Consumer Products Inc.-28.57%$ -28.571 
National Healthcare Corp-28.78%$ -28.777 
Incyte Corp-29.17%$ -29.167 
Semler Scientific inc.-31.51%$ -31.507 
Align Technology inc.-32.68%$ -32.677 
Laboratory Corporation Of America Holdings-33.12%$ -33.122 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UMH's Profile

Stock Price

UMH's Financials

Business Description

Fundamentals

Charts & Quotes

UMH's News

Suppliers

UMH's Competitors

Customers & Markets

Economic Indicators

UMH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071